title: Comment on Kramer et al. Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia. Diabetes Care 2014;37:1076-1082.
authors.affiliation: Department of Diabetes, Endocrinology, and Metabolism, National Center for Global Health and Medicine, Tokyo, Japan.
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Takahashi
authors.affiliation: Department of Diabetes, Endocrinology, and Metabolism, National Center for Global Health and Medicine, Tokyo, Japan ttsujimoto@hosp.ncgm.go.jp.
authors.forename: Tetsuro
authors.initials: T
authors.lastname: Tsujimoto
authors.affiliation: Department of Diabetes, Endocrinology, and Metabolism, National Center for Global Health and Medicine, Tokyo, Japan ttsujimoto@hosp.ncgm.go.jp.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kajio
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D002239:Carbohydrate Metabolism, Inborn Errors / Q000097:blood*; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism*; D005260:Female; D005934:Glucagon / Q000097:blood*; D005947:Glucose / Q000008:administration & dosage*; D005991:Glycerol Kinase / Q000172:deficiency*; D006801:Humans; D008297:Male
chemical_list: D001786:Blood Glucose; D005934:Glucagon; D005991:Glycerol Kinase; D005947:Glucose